Yossi Maimon

Protalix BioTherapeutics

Vice President, Chief Financial Officer

Overview

Yossi Maimon made an average of $649.5K in compensation at Protalix BioTherapeutics from 2006 to 2018.

Annual data

2018

In 2018, Yossi Maimon earned a total compensation of $557.6K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking9,172 out of 10,934
Percentile16.1%

Yossi Maimon's 2018 compensation ranked 9,172nd out of 10,934 executive pay records tracked by us this year.

Maimon earned more than 16.1% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,099 out of 1,246
Percentile11.8%

In the industry group of Drugs, Maimon's pay ranked 1,099th out of 1,246 executive pay records tracked by us in 2018.

Maimon earned more than 11.8% of executives in this group.

Bonus$140,000
Option Awards$59,089
Salary$282,649
Other$75,813
Total$557,551

Maimon received $282.6K in salary, which accounts for 50.69% of total compensation.

Maimon also received $140K in bonus, $59.1K in option awards and $75.8K in other compensation.

Yossi Maimon's Pay$557,551
Median Employee's Pay$47,782
Pay Ratio12 : 1

For fiscal year 2018, the annual total compensation for Yossi Maimon was $557,551 and for the median employee at Protalix BioTherapeutics was $47,782. The resulting ratio of Yossi Maimon's pay to the pay of median employee was 12 to one.

2017

In 2017, Yossi Maimon earned a total compensation of $759K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking9,661 out of 13,778
Percentile29.9%

Yossi Maimon's 2017 compensation ranked 9,661st out of 13,778 executive pay records tracked by us this year.

Maimon earned more than 29.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,050 out of 1,566
Percentile33.0%

In the industry group of Drugs, Maimon's pay ranked 1,050th out of 1,566 executive pay records tracked by us in 2017.

Maimon earned more than 33.0% of executives in this group.

Bonus$363,647
Option Awards$37,686
Salary$282,197
Other$75,448
Total$758,978

Maimon received $363.6K in bonus, which accounts for 47.91% of total compensation.

Maimon also received $37.7K in option awards, $282.2K in salary and $75.4K in other compensation.

2016

In 2016, Yossi Maimon earned a total compensation of $444.8K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking11,575 out of 14,038
Percentile17.5%

Yossi Maimon's 2016 compensation ranked 11,575th out of 14,038 executive pay records tracked by us this year.

Maimon earned more than 17.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,279 out of 1,500
Percentile14.7%

In the industry group of Drugs, Maimon's pay ranked 1,279th out of 1,500 executive pay records tracked by us in 2016.

Maimon earned more than 14.7% of executives in this group.

Option Awards$93,890
Salary$264,696
Stock Awards$16,043
Other$70,153
Total$444,782

Maimon received $264.7K in salary, which accounts for 59.51% of total compensation.

Maimon also received $93.9K in option awards, $16K in stock awards and $70.2K in other compensation.

2015

In 2015, Yossi Maimon earned a total compensation of $780.5K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking9,074 out of 13,589
Percentile33.2%

Yossi Maimon's 2015 compensation ranked 9,074th out of 13,589 executive pay records tracked by us this year.

Maimon earned more than 33.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,005 out of 1,485
Percentile32.3%

In the industry group of Drugs, Maimon's pay ranked 1,005th out of 1,485 executive pay records tracked by us in 2015.

Maimon earned more than 32.3% of executives in this group.

Bonus$246,009
Option Awards$102,215
Salary$266,776
Stock Awards$97,120
Other$68,398
Total$780,518

Maimon received $266.8K in salary, which accounts for 34.18% of total compensation.

Maimon also received $246K in bonus, $102.2K in option awards, $97.1K in stock awards and $68.4K in other compensation.

2014

In 2014, Yossi Maimon earned a total compensation of $860K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking8,198 out of 12,932
Percentile36.6%

Yossi Maimon's 2014 compensation ranked 8,198th out of 12,932 executive pay records tracked by us this year.

Maimon earned more than 36.6% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking796 out of 1,316
Percentile39.5%

In the industry group of Drugs, Maimon's pay ranked 796th out of 1,316 executive pay records tracked by us in 2014.

Maimon earned more than 39.5% of executives in this group.

Bonus$225,000
Option Awards$56,170
Salary$299,090
Stock Awards$205,244
Other$74,493
Total$859,997

Maimon received $299.1K in salary, which accounts for 34.78% of total compensation.

Maimon also received $225K in bonus, $56.2K in option awards, $205.2K in stock awards and $74.5K in other compensation.

2013

In 2013, Yossi Maimon earned a total compensation of $974.8K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking6,664 out of 12,071
Percentile44.8%

Yossi Maimon's 2013 compensation ranked 6,664th out of 12,071 executive pay records tracked by us this year.

Maimon earned more than 44.8% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking507 out of 1,102
Percentile54.0%

In the industry group of Drugs, Maimon's pay ranked 507th out of 1,102 executive pay records tracked by us in 2013.

Maimon earned more than 54.0% of executives in this group.

Bonus$110,000
Option Awards$126,208
Salary$292,096
Stock Awards$378,745
Other$67,739
Total$974,788

Maimon received $378.7K in stock awards, which accounts for 38.85% of total compensation.

Maimon also received $110K in bonus, $126.2K in option awards, $292.1K in salary and $67.7K in other compensation.

2012

In 2012, Yossi Maimon earned a total compensation of $1.4M as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking4,770 out of 11,148
Percentile57.2%

Yossi Maimon's 2012 compensation ranked 4,770th out of 11,148 executive pay records tracked by us this year.

Maimon earned more than 57.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking248 out of 863
Percentile71.3%

In the industry group of Drugs, Maimon's pay ranked 248th out of 863 executive pay records tracked by us in 2012.

Maimon earned more than 71.3% of executives in this group.

Bonus$157,500
Option Awards$544,199
Salary$268,618
Stock Awards$361,048
Other$58,231
Total$1,389,596

Maimon received $544.2K in option awards, which accounts for 39.16% of total compensation.

Maimon also received $157.5K in bonus, $268.6K in salary, $361K in stock awards and $58.2K in other compensation.

2011

In 2011, Yossi Maimon earned a total compensation of $373.8K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking8,590 out of 10,255
Percentile16.2%

Yossi Maimon's 2011 compensation ranked 8,590th out of 10,255 executive pay records tracked by us this year.

Maimon earned more than 16.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking587 out of 716
Percentile18.0%

In the industry group of Drugs, Maimon's pay ranked 587th out of 716 executive pay records tracked by us in 2011.

Maimon earned more than 18.0% of executives in this group.

Option Awards$18,304
Salary$286,220
Other$69,290
Total$373,814

Maimon received $286.2K in salary, which accounts for 76.57% of total compensation.

Maimon also received $18.3K in option awards and $69.3K in other compensation.

2010

In 2010, Yossi Maimon earned a total compensation of $419.5K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking7,861 out of 9,770
Percentile19.5%

Yossi Maimon's 2010 compensation ranked 7,861st out of 9,770 executive pay records tracked by us this year.

Maimon earned more than 19.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking503 out of 636
Percentile20.9%

In the industry group of Drugs, Maimon's pay ranked 503rd out of 636 executive pay records tracked by us in 2010.

Maimon earned more than 20.9% of executives in this group.

Bonus$20,000
Option Awards$63,175
Salary$268,154
Other$68,156
Total$419,485

Maimon received $268.2K in salary, which accounts for 63.92% of total compensation.

Maimon also received $20K in bonus, $63.2K in option awards and $68.2K in other compensation.

2009

In 2009, Yossi Maimon earned a total compensation of $640.6K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking5,635 out of 9,044
Percentile37.7%

Yossi Maimon's 2009 compensation ranked 5,635th out of 9,044 executive pay records tracked by us this year.

Maimon earned more than 37.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking297 out of 593
Percentile49.9%

In the industry group of Drugs, Maimon's pay ranked 297th out of 593 executive pay records tracked by us in 2009.

Maimon earned more than 49.9% of executives in this group.

Bonus$160,000
Option Awards$253,030
Salary$186,478
Other$41,051
Total$640,559

Maimon received $253K in option awards, which accounts for 39.50% of total compensation.

Maimon also received $160K in bonus, $186.5K in salary and $41.1K in other compensation.

2008

In 2008, Yossi Maimon earned a total compensation of $555.8K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking5,676 out of 8,153
Percentile30.4%

Yossi Maimon's 2008 compensation ranked 5,676th out of 8,153 executive pay records tracked by us this year.

Maimon earned more than 30.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking315 out of 555
Percentile43.2%

In the industry group of Drugs, Maimon's pay ranked 315th out of 555 executive pay records tracked by us in 2008.

Maimon earned more than 43.2% of executives in this group.

Bonus$30,659
Option Awards$238,194
Salary$203,097
Other$83,808
Total$555,758

Maimon received $238.2K in option awards, which accounts for 42.86% of total compensation.

Maimon also received $30.7K in bonus, $203.1K in salary and $83.8K in other compensation.

2007

In 2007, Yossi Maimon earned a total compensation of $523.5K as Chief Financial Officer at Protalix BioTherapeutics.

Ranking5,252 out of 7,438
Percentile29.4%

Yossi Maimon's 2007 compensation ranked 5,252nd out of 7,438 executive pay records tracked by us this year.

Maimon earned more than 29.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking312 out of 486
Percentile35.8%

In the industry group of Drugs, Maimon's pay ranked 312th out of 486 executive pay records tracked by us in 2007.

Maimon earned more than 35.8% of executives in this group.

Bonus$77,223
Option Awards$247,815
Salary$156,444
Other$41,975
Total$523,457

Maimon received $247.8K in option awards, which accounts for 47.34% of total compensation.

Maimon also received $77.2K in bonus, $156.4K in salary and $42K in other compensation.

2006

In 2006, Yossi Maimon earned a total compensation of $164.5K as Chief Financial Officer at Protalix BioTherapeutics.

Ranking5,558 out of 5,855
Percentile5.1%

Yossi Maimon's 2006 compensation ranked 5,558th out of 5,855 executive pay records tracked by us this year.

Maimon earned more than 5.1% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking416 out of 445
Percentile6.5%

In the industry group of Drugs, Maimon's pay ranked 416th out of 445 executive pay records tracked by us in 2006.

Maimon earned more than 6.5% of executives in this group.

Bonus$31,953
Option Awards$96,712
Salary$27,746
Other$8,077
Total$164,488

Maimon received $96.7K in option awards, which accounts for 58.80% of total compensation.

Maimon also received $32K in bonus, $27.7K in salary and $8.1K in other compensation.